Summary of Classification and Labelling
Notified classification and labelling
General Information
814-272-0 |
4-[8-amino-3-[(2S)-1-(1-oxo-2-butyn-1-yl)-2-pyrrolidinyl]imidazo[1,5-a]pyrazin-1-yl]-N-2-pyridinylbenzamide |
1420477-60-6 |
Notified classification and labelling according to CLP criteria
STOT RE 2 |
H373
(Lymphatic syste...)
(oral)
|
H373
|
|
GHS08 Wng
|
|
|
|
|
1 |
|
View details
|
STOT RE 2 |
H373
(other:Lymphatic...)
(oral)
|
H373
|
Not Classified |
|
|
|
|
|
|
|
|
1 |
|
|
Number of Aggregated Notifications: 2